Scholarly publications and presentations by Rochester Regional Health's Radiation Oncology department authors.
Submissions from 2024
11-1-2024 Surgical Margins After Neoadjuvant Radiation for Locally Advanced Vulvar Carcinoma: What is an Adequate Margin?, Michelle Ertel, John A. Vargo, Anna Weimer, et al.
10-8-2024 Technical Innovations and New Therapies to Optimize Functional Outcomes After Radiation Therapy, Marisa Kollmeier and Benjamin Silver, Rochester Regional Health
9-1-2024 External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline, Sara Alcorn, Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota., Ángel Artal Cortés, Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain., Lisa Bradfield, American Society for Radiation Oncology, Arlington, Virginia., et al.
7-1-2024 Key factors for establishing and sustaining a successful palliative radiation oncology program: a survey of the Society for Palliative Radiation Oncology, Deborah C. Marshall, Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kavita Dharmarajan, Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Randy Wei, Memorial Radiation Oncology Medical Group, Long Beach, CA, USA., et al.
7-1-2024 Palliative Care for Patients With Cancer: ASCO Guideline Update, Justin J. Sanders, McGill University, Montreal, Canada., Sarah Temin, American Society of Clinical Oncology (ASCO), Alexandria, VA., Arun Ghoshal, Princess Margaret Cancer Centre, Toronto, ON, Canada., et al.
5-2024 Oncologist in my Pocket: What the Palliative Clinician Needs to Know About Hematology, Oncology and Radiation Oncology, Kristina Newport, Shanthi Sivendran, Thomas W. Leblanc, et al.
Submissions from 2023
5-23-2023 Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma, Tugce Kutuk, Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA., Joshua M. Walker, Department of Radiation Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Matthew T. Ballo, Department of Radiation Oncology, West Cancer Center & Research Institute, Memphis, TN 38138, USA., et al.
2-2023 74MO Clinical outcomes for pelvic node-positive vulvar carcinoma in the PET and IMRT era: Reassessing the stage IVb designation, S. A. Koerner, UPMC Hillman Cancer Center, Pittsburgh, PA, M. Schad, University of Pittsburgh, Pittsburgh, PA, B. Elgohari, UPMC Hillman Cancer Center, Pittsburgh, PA, et al.
Submissions from 2022
9-2022 EP07.01-019 Multiinstitutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma, T. Kutuk, Miami Cancer Institute, Miami, FL; J. Walker, Oregon Health & Science University, Portland, OR; and Sheema Chawla, Rochester Regional Health
Submissions from 2020
6-1-2020 Comparing medical grade to commercial grade display in a radiation oncology environment, Adi Robinson, Rochester Regional Health and Mark D. Fairchild, Munsell Color Science Laboratory, Rochester Institute of Technology, Rochester NY 14623, USA.
Submissions from 2017
3-1-2017 Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ, Jennifer B. Manders, The Christ Hospital - Cincinnati, Henry M. Kuerer, University of Texas MD Anderson Cancer Center, Sheema Chawla, Rochester Regional Health, et al.
Submissions from 2016
10-1-2016 Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?, Nam P. Nguyen, Juan Godinez, Rochester Regional Health, Wei Shen, et al.